APA (7th ed.) Citation

M. Lee, S. Collins, S. Kinloch, J. Fox, K. Seaton, G. Tomaras, . . . S. Fidle. (2022). OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: Four cases from the open label arm of the RIO trial. Elsevier.

Chicago Style (17th ed.) Citation

M. Lee, et al. OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on Viral Rebound Dynamics Following Treatment Interruption Six Months After Dosing: Four Cases from the Open Label Arm of the RIO Trial. Elsevier, 2022.

MLA (9th ed.) Citation

M. Lee, et al. OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on Viral Rebound Dynamics Following Treatment Interruption Six Months After Dosing: Four Cases from the Open Label Arm of the RIO Trial. Elsevier, 2022.